MARIANNA ALMANZA: Open Payments
NPI 1720542491 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 30 payments from 9 companies in 2025. Trend: 2023 $1,217 · 2024 $794 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $183 |
| Lilly USA, LLC | 1 | $112 |
| LEO Pharma Inc. | 4 | $88 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Biofrontera Inc. | 2 | $46 |
| GENZYME CORPORATION | 2 | $43 |
| UCB, Inc. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: EBGLYSS, ADBRY, COSENTYX, DUPIXENT, Bimzelx, RINVOQ, SKYRIZI, BOTOX.
Industry payments across CA — which companies pay providers there.
